Video from AACC: AACC president on Theranos, VALID Act

By Leo O'Connor, Editor in Chief
August 1, 2022

Dr. Stephen Master, president of the American Association for Clinical Chemistry, provided his thoughts about the main highlights of the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo held this week in Chicago.

Dr. Master discussed key takeaways from a fireside chat he moderated on Tuesday involving two of the whistleblowers who helped bring down Theranos, as well as the implications of the VALID Act for laboratories and IVD companies.

Click on the video below for the interview.

Dr. Master Interview
Dr. Stephen Master, president of the American Association for Clinical Chemistry.

Theranos whistleblowers to speak at AACC Expo
The American Association for Clinical Chemistry (AACC) announced on Wednesday that Erika Cheung and Tyler Shultz, two of the whistleblowers who helped...
AACC expresses concern about rush to pass VALID Act
The American Association for Clinical Chemistry (AACC) on Monday announced that it has joined more than 100 medical and patient organizations to express...
AACC lobbies against greater regulation of lab-developed tests
The American Association for Clinical Chemistry (AACC) is urging Congress to not include a bill to mandate greater regulatory oversight of laboratory-developed...
Theranos founder Holmes found guilty on fraud charges
Elizabeth Holmes, the founder of defunct blood testing firm Theranos, was found guilty of four charges of fraud on January 3 by a jury in California....
Holder of Theranos patents draws fire for lawsuit
A company that holds a number of patents purchased from disgraced diagnostics developer Theranos is drawing criticism for a patent infringement lawsuit...

Copyright © 2022 LabPulse.com

Last Updated mp 8/1/2022 1:02:26 PM